Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Janet Rowan FRACP

Janet A. Rowan FRACP

Consultant Physician, National Women’s Heath, Auckland City Hospital, Auckland, New Zealand

Dr. Rowan is a recently retired clinician and Team Leader of the Maternity Diabetes Service at National Women’s Health. She has an ongoing role with teaching, mentoring and research.

Dr. Rowan was the principal investigator for the Metformin in Gestational Diabetes Trial (MiG) and the follow-up studies of the offspring up to 9 years (MiG TOFU). Her research interests include examining the role of HbA1c in early pregnancy to diagnose underlying hyperglycaemia in pregnancy and the threshold for diagnosis GDM in New Zealand.

Dr. Rowan has published approximately 50 publications relating to diabetes in pregnancy, most related to research interests above.


Dr. Rowan was the principal investigator of the Metformin in Gestational diabetes trial (MiG Trial) and the offspring follow-up (MiG TOFU)  to 9 years of age.